logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Jiuqiang Bio (300406.SZ) obtained a medical device registration certificate.

date
02/09/2025
Wisdom Financial News APP news, Jiuqiang Biotechnology (300406.SZ) announced that the company recently received the "Medical Device Registration Certificate" issued by the Beijing Municipal Drug Administration, with the product name: Gastrin-17 Assay Kit (Latex Immunoturbidimetry). This assay kit is used for the quantitative determination of gastrin-17 (G-17) content in human serum in vitro.
Latest
3 m ago
The Nasdaq index just broke through the 21200.00 mark, with the latest reported at 21200.19, down 1.19% for the day.
3 m ago
The Nasdaq index just broke through the 21,200.00 level, with the latest report at 21,200.19, down 1.19% in the day.
4 m ago
S&P Global: US August output growth strengthened due to increased sales and inventory accumulation. Tariffs once again drove prices and output charges sharply higher. With improved confidence, employment increased significantly.
4 m ago
Standard & Poor's Global: US output growth strengthens in August due to increased sales and inventory accumulation. Tariffs once again drive prices and output charges higher. Significant increase in employment as confidence improves.
4 m ago
U.S. stock market anomaly | BeiGene's (ONC.US) Surges Over 9%, with a 46% Increase in Revenue in the First Half of 2025.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.